Hind. Unilever Q2 FY27 Earnings Call — Analysis (NSE: HINDUNILVR)
HUL delivered its highest Underlying Sales Growth in 14 quarters at 15% with 7% volume growth in Q2FY27, while navigating a 400 bps gross margin contraction via calibrated pricing and operational leverage to maintain EBITDA margins at 22.6%.
Result quality: watch — Margin pressure. Management sentiment: optimistic.
The take
Q2FY27 PAT before Exceptional Items ₹2,795 Cr ( +9% YoY ) . New guidance — FY27-28 medium-term ebitda margin 22% to 24% . New story: Broad-based volume recovery .
Results
Turnover ₹18,071 Cr (+15% USG YoY, +7% UVG); EBITDA ₹4,089 Cr (+8% YoY) with margin at 22.6% (-140 bps YoY); PAT bei ₹2,795 Cr (+9% YoY).
Financial highlights
| Metric | Value | Change | Basis |
|---|---|---|---|
| Turnover | ₹18,071 Cr | +15% | yoy · Q2FY27 · Underlying Sales Growth |
| Underlying Volume Growth | 7% | none · Q2FY27 · UVG YoY | |
| EBITDA | ₹4,089 Cr | +8% | yoy · Q2FY27 |
| EBITDA Margin | 22.6% | -140bps | yoy · Q2FY27 |
| PAT before Exceptional Items | ₹2,795 Cr | +9% | yoy · Q2FY27 |
| H1 Turnover | ₹35,255 Cr | +12% | yoy · H1FY27 · Underlying Sales Growth |
| H1 PAT before Exceptional Items | ₹5,500 Cr | +9% | yoy · H1FY27 · H1 PAT bei growth stated at 9% |
| Interim Dividend Per Share | ₹19 | point_in_time · FY27 · Interim dividend for FY27 |
Guidance
Medium-term EBITDA margin expected to remain within the guided range of 22% to 24% with structurally improving gross margins over 3-5 years.
What management committed to
- HUL expects medium-term EBITDA Margin to be within the current guided range of 22% to 24%. — 22% to 24%, FY27-28
- HUL will fix the subdued performance in [Health & Wellbeing], including [OZiva], in the coming quarters. — coming quarters
- HUL remains confident of growing ahead of the market. — ongoing
- HUL sees significant opportunity to build its presence in the protein category with [Horlicks Protein Powder]. — medium-term
Key themes
Volume-led revenue growth amid commodity inflation
How the narrative shifted
- Broad-based volume recovery: Broad-based volume-led growth accelerated sharply to 15% USG and 7% UVG, the highest in 14 quarters, confirming a strong demand platform and market resilience.
- Premiumization across portfolio: Premiumisation is a structural growth engine with double-digit growth across premium formats (Surf excel Easy Wash, Dove, Minimalist), supporting margin trajectory and portfolio transformation.
- Margin discipline amid commodity inflation: The guided EBITDA margin range was officially broadened from ~23% to 22-24%, attributing the shift to managing cyclical cost inflation while reaffirming structural improvement over a longer horizon.
- Digital and supply chain moats: AI and supply chain agility are framed as core competitive moats enabling executional excellence and resilience, validated by external recognition ('Top Supply Chain Icon').
- Navigating external volatility (monsoon, crude, geopolitics): Management continues to monitor commodity volatility and the monsoon deficit but reinforces limited impact on HUL's demand given the reduced weight of agriculture in GDP and social support schemes.
- Quick commerce as structural growth channel: Quick commerce is framed as a structurally beneficial premium channel enabling segmentation of affluent consumers and repertoire growth for HUL's portfolio through joint category development with platforms.
- Winning In New India (WINI) strategic framework: This is an entirely new, formalized strategic articulation compared to the prior call's more thematic focus on volume recovery and specific initiatives.
Operational commentary
- Added 30,000 general trade outlets during Q2FY27 while delivering healthy double-digit assortment growth across channels.
- Nearly doubled in-store visibility asset deployment in modern trade over the last two quarters to drive category development.
- Launched Horlicks Protein Powder extending the nutrition franchise into the fast-growing everyday protein market.
- Expanded Simple skincare with a pro-ceramide barrier repair range for sensitive skin and accelerated offline distribution for Minimalist.
- Maintained direct-supply fulfillment model for quick commerce partners, leveraging the channel to scale premium product assortments.
Analyst Q&A
Q. Are gross margins bottoming out given ~400 bps contraction and 8% pricing growth, or will further hikes be required?
Significant inflation was absorbed in Q1 and Q2; pricing was calibrated to cover absolute cost, causing EBITDA margin to fall just 40 bps QoQ. While future inflation is unpredictable, calibrated price increases will continue as necessary.
Q. Why did A&P to sales drop to historic lows, and is there risk of under-investing in brand building?
A&P to sales ratio is not the primary metric; SOV:SOM increased from 1.0 to 1.1, and scale efficiencies plus AI tools (Sangam) generated ~10% productivity savings. Home Care A&P was selectively cut by ~₹250 Cr while spends in other categories were stepped up.
Q. What is driving Lifebuoy's sustained underperformance in soaps and what remedial steps are being taken?
Consumer demand is shifting from mass hygiene to premium beauty and liquid formats where HUL's portfolio is gaining share, while specific interventions like Lifebuoy Ice Bath have been launched to protect mass competitiveness.
Research and educational content only. Not investment advice.